Does Purdue Pharma still exist?
No — the plan dissolved the company and transferred its assets to Knoa Pharma, an independent foundation focused on opioid treatment and overdose reversal, with no Sackler involvement.
No. The plan dissolved Purdue and transferred its assets to a new company, Knoa Pharma, owned by an independent foundation and focused on supplying opioid use disorder treatments and overdose-reversal medicines with no obligation to maximise profits. The Sacklers have no interest or role in it, and it operates under a strict injunction overseen by a monitor. The plan went into effect on May 1, 2026.
The sheer scale of the case is reflected in the more than $40 trillion in creditor claims filed during the bankruptcy. The end of Purdue does not end the controversy: people who declined to opt into the releases retain the right to sue individual Sackler family members.
